Posters
| Name | Organization | Job Title/Position | Abstract Title | Abstract Category |
|---|---|---|---|---|
| Santiago Navarro | Texas A&M University | PhD Student | Evaluation of MVA plaque assay by crystal violet staining in continuous chicken embryo fibroblasts DF-1 | Viral Vectors & Vaccine Development |
| Dr. Jingxin Cao | National Microbiology Laboratory | Principal Investigator | E3L deletion mutant vaccinia/NYCBH as a platform for recombinant vaccine: expression of the spike and the nucleocapsid proteins protect against SARS-CoV-2 infection in hamsters | Viral Vectors & Vaccine Development |
| Dr Rafael Blasco | INIA CSIC | Principal Investigator | Dissecting the transcriptome of a replication competent Poxvirus infection at single cell resolution | Virus-Host Cell Interaction & Signalling |
| Mr. Vaughn Wicker | ORAU | ORISE Post-baccalaureate Research Fellow | Development of new real-time PCR assays to improve the detection of Mpox virus (MPXV) variants | Emerging Poxviruses |
| Dr Stephen Laidlaw | University of Oxford | Postdoctoral Fellow | Development & Assessment of a Lateral Flow Device for Detection of Mpox and Other Orthopoxviruses | Viral Pathogenesis & Therapeutics |
| Mrs Pia Veratti | University Hospital Freiburg | Research Assistant | Comparative poxvirus transcriptomics | Gene Expression & Genome Replication |
| Preetam Parija | University of Surrey | PhD Student | A role for the E3 ligase FBXO22 in antiviral immunity and its antagonism by orthopoxviruses | Virus-Host Cell Interaction & Signalling |
| Dr Susana Guerra | Autonomous University of Madrid | Principal Investigator | An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses | Viral Vectors & Vaccine Development |
| Ms. Kimberly Wilkins | Centers for Disease Control and Prevention | Research Assistant | Analysis of mpox testing at the CDC during the 2022 multinational mpox outbreak | Viral Genomics & Proteomics |
| Name | Organization | Job Title/Position | Abstract Title | Abstract Category |
|---|---|---|---|---|
| Mr. Michael Townsend | Centers for Disease Control and Prevention | Microbiologist / B.S. | Demonstration of acute phase anti-orthopoxvirus IgM response from clinical sample testing during the 2022 multinational mpox outbreak | Emerging Poxviruses |
| Dr. Jingxin Cao | National Microbiology Laboratory | Principal Investigator | Application of VACV E3L and K3L double deletion system to reveal SARS-CoV-2 N as an inhibitor of PKR and OAS/RNase L antiviral pathways | Virus-Host Cell Interaction & Signalling |
| Ngadhnjim Latifi | University Hospital Tübingen | Scientist | A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge | Viral Vectors & Vaccine Development |